Click image to view original image
CAS No: 54965-24-1
Chemical Name: (Z)-2-[4-(1, 2-Diphenyl-1-butenyl)phenoxyl]-N, N-dimethyl-ethanamine-citrate;
1-p-beta-Dimethylaminoethoxyphenyl-trans-1, 2-diphenylbut-1-ene citrate;
Molecular Formula: C26H29NO. C6H8O7
Molecular weight: 563.64
CAS No.: 54965-24-1 
Appearance: White crystalline powder; MP: 140-144
Function:
Tamoxifen is an anticancer drug, is given to treat breast cancer.
Tamoxifen citrate is an anticancer drug, is given to treat breast cancer. It also has proved effective when cancer has spread to other parts of the body. Tamoxifen citrate is most effective in stopping the kind of breast cancer that thrives on estrogen.
Tamoxifen citrateis also prescribed to reduce the risk of invasive breast cancer following surgery and radiation therapy for ductal carcinoma in situ. The drug can also be used to reduce the odds of breast cancer in women at high risk of developing the disease. It does not completely eliminate your chances, but in a five-year study of over 1, 500 high-risk women, it slashed the number of cases by 44 percent.
Most
Although Tamoxifen citrate reduces the risk of breast cancer, it increases the possibility of developing endometrial (uterine) cancer. Women taking Tamoxifen citrate should have routine gynecological examinations and report any abnormal vaginal bleeding, changes in menstrual periods, change in vaginal discharge, or pelvic pain or pressure to the doctor immediately. Even after Tamoxifen citratetherapy has stopped, any abnormal vaginal bleeding should be reported at once.
